NOVELLA CLINICAL Trademark

Trademark Overview

On Wednesday, February 18, 2009, a trademark application was filed for NOVELLA CLINICAL with the United States Patent and Trademark Office. The USPTO has given the NOVELLA CLINICAL trademark a serial number of 77673351. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, August 19, 2020. This trademark is owned by PHARMALINKFHI, INC.. The NOVELLA CLINICAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

The design and testing of new products and devices for others on behalf of biotechnology, medical devices and pharmaceutical companies
novella clinical

General Information

Serial Number77673351
Word MarkNOVELLA CLINICAL
Filing DateWednesday, February 18, 2009
Status800 - REGISTERED AND RENEWED
Status DateWednesday, August 19, 2020
Registration Number3880642
Registration DateTuesday, November 23, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2009

Trademark Statements

Disclaimer with Predetermined Text"CLINICAL"
Goods and ServicesThe design and testing of new products and devices for others on behalf of biotechnology, medical devices and pharmaceutical companies
Translation of Words in MarkThe English translation of "NOVELLA" in the mark is a tale, a piece of news derived from the Italian word "novella".

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 23, 2009
Primary Code042
First Use Anywhere DateSunday, June 21, 2009
First Use In Commerce DateSunday, June 21, 2009

Trademark Owner History

Party NameIQVIA BIOTECH LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressWILMINGTON, DE 19801
Party NameNovella Clinial, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressMORRISVILLE, NC 27560
Party NameNOVELLA CLINICAL INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560
Party NameNOVELLA CLINICAL INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDURHAM, NC 27703
Party NameNOVELLA CLINICAL INC.
Party Type12 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressDURHAM, NC 27703
Party NameNOVELLA CLINICAL INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressDURHAM, NC 27703
Party NamePHARMALINKFHI, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events

Event DateEvent Description
Wednesday, August 19, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, August 19, 2020REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, August 19, 2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, August 18, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 30, 2020TEAS SECTION 8 & 9 RECEIVED
Saturday, November 23, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, May 29, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, November 21, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 21, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 17, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, August 17, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, July 26, 2017TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, January 26, 2017POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Thursday, January 26, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 16, 2016TEAS SECTION 8 & 15 RECEIVED
Wednesday, October 19, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, October 12, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, October 5, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, September 28, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 28, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 27, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, May 20, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, October 30, 2013ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, November 23, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, October 19, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, October 18, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, October 18, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 19, 2010STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 21, 2010USE AMENDMENT FILED
Thursday, August 19, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 21, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, February 2, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 10, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2009PUBLISHED FOR OPPOSITION
Wednesday, October 7, 2009ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, October 6, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 6, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 30, 2009AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, September 30, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 30, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 29, 2009ASSIGNED TO LIE
Friday, September 25, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 8, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 8, 2009NON-FINAL ACTION E-MAILED
Friday, May 8, 2009NON-FINAL ACTION WRITTEN
Thursday, May 7, 2009ASSIGNED TO EXAMINER
Monday, February 23, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 21, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

clinical novella devices medical pharmaceutical companies biotechnology others testing products design behalf